Matthew Cooper

Person

Cambridge, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Sulfonamide derivates as NLRP3 inhibitors
- Patent number 12,168,653
- Issue date Dec 17, 2024
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonyl acetamides as NLRP3 inhibitors
- Patent number 12,030,879
- Issue date Jul 9, 2024
- Inflazome Limited
- Matthew Cooper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonamide carboxamide compounds
- Patent number 12,012,392
- Issue date Jun 18, 2024
- Inflazome Limited
- Matthew Cooper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonamide carboxamide compounds
- Patent number 11,981,667
- Issue date May 14, 2024
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
- Patent number 11,926,600
- Issue date Mar 12, 2024
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 11,905,252
- Issue date Feb 20, 2024
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonyl acetamides as NLRP3 inhibitors
- Patent number 11,884,645
- Issue date Jan 30, 2024
- Inflazome Limited
- David Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 11,834,433
- Issue date Dec 5, 2023
- Inflazome Limited
- David Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
- Patent number 11,613,542
- Issue date Mar 28, 2023
- Inflazome Limited
- Matthew Cooper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
- Patent number 11,542,255
- Issue date Jan 3, 2023
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 11,530,200
- Issue date Dec 20, 2022
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide carboxamide compounds
- Patent number 11,465,992
- Issue date Oct 11, 2022
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of SOX18 protein activity for treating angiogenesis-and/...
- Patent number 11,434,190
- Issue date Sep 6, 2022
- The University of Queensland
- Mathias Francois
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
- Patent number 11,370,776
- Issue date Jun 28, 2022
- Inflazome Limited
- Matthew Cooper
- G01 - MEASURING TESTING
Information Patent Grant
Measurement and use of molecular interactions
- Patent number 7,763,475
- Issue date Jul 27, 2010
- Inverness Medical Switzerland GmbH
- David Klenerman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibacterial agents comprising conjugates of glycopeptides and pep...
- Patent number 7,078,380
- Issue date Jul 18, 2006
- Cambridge University Technical Services Limited
- Matthew Allister Cooper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AND USE THEREOF IN METHODS OF TREATMENT
- Publication number 20240002326
- Publication date Jan 4, 2024
- The University of Queensland
- Mathias FRANCOIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS
- Publication number 20230121952
- Publication date Apr 20, 2023
- Inflazome Limited
- Matthew COOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF SOX18 PROTEIN ACTIVITY FOR TREATING ANGIOGENESIS AND/...
- Publication number 20230100768
- Publication date Mar 30, 2023
- The University of Queensland
- Mathias FRANCOIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20230037255
- Publication date Feb 2, 2023
- INFLAZOME LIMITED
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF AUTOINFLAMMATORY DISORDERS
- Publication number 20220409585
- Publication date Dec 29, 2022
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT AND PREVENTION OF NEUROINFLAMMATION OR AN INFLAMMATORY BR...
- Publication number 20220409586
- Publication date Dec 29, 2022
- Inflazome Limited
- Matthew COOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT AND PREVENTION OF A NEURODEGENERATIVE DISORDER
- Publication number 20220401414
- Publication date Dec 22, 2022
- Inflazome Limited
- Matthew COOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF ARTHRITIS
- Publication number 20220395490
- Publication date Dec 15, 2022
- Inflazome Limited
- Matthew COOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS
- Publication number 20220389031
- Publication date Dec 8, 2022
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS
- Publication number 20220289766
- Publication date Sep 15, 2022
- INFLAZOME LIMITED
- Matthew COOPER
- G01 - MEASURING TESTING
Information Patent Application
NOVEL SULFONAMIDEUREA COMPOUNDS
- Publication number 20220194923
- Publication date Jun 23, 2022
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 INFLAMMASOME INHIBITION
- Publication number 20220163539
- Publication date May 26, 2022
- Inflazome Limited
- Matthew COOPER
- G01 - MEASURING TESTING
Information Patent Application
NLRP3 INHIBITORS
- Publication number 20220106289
- Publication date Apr 7, 2022
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20210347737
- Publication date Nov 11, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHENYLSULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS
- Publication number 20210332020
- Publication date Oct 28, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHENYLSULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS
- Publication number 20210147349
- Publication date May 20, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS
- Publication number 20210130359
- Publication date May 6, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS
- Publication number 20210130329
- Publication date May 6, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20210122739
- Publication date Apr 29, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS
- Publication number 20210122716
- Publication date Apr 29, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20210047302
- Publication date Feb 18, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20210040065
- Publication date Feb 11, 2021
- Inflazome Limited
- David MILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20210002274
- Publication date Jan 7, 2021
- Inflazome Limited
- Matthew COOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFONAMIDE DERIVATES AS NLRP3 INHIBITORS
- Publication number 20200407340
- Publication date Dec 31, 2020
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20200399243
- Publication date Dec 24, 2020
- Inflazome Limited
- David MILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20200399242
- Publication date Dec 24, 2020
- Inflazome Limited
- David MILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20200361895
- Publication date Nov 19, 2020
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20200354341
- Publication date Nov 12, 2020
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20200317637
- Publication date Oct 8, 2020
- Matthew COOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20200291003
- Publication date Sep 17, 2020
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY

Matthew Cooper

Person

Patents Grantslast 30 patents

Sulfonamide derivates as NLRP3 inhibitors

Sulfonyl acetamides as NLRP3 inhibitors

Sulfonamide carboxamide compounds

Sulfonamide carboxamide compounds

Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Compounds

Sulfonyl acetamides as NLRP3 inhibitors

Compounds

Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Compounds

Sulfonamide carboxamide compounds

Inhibitors of SOX18 protein activity for treating angiogenesis-and/...

Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Measurement and use of molecular interactions

Antibacterial agents comprising conjugates of glycopeptides and pep...

Patents Applicationslast 30 patents

COMPOUNDS AND USE THEREOF IN METHODS OF TREATMENT

COMPOUNDS

INHIBITORS OF SOX18 PROTEIN ACTIVITY FOR TREATING ANGIOGENESIS AND/...

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

TREATMENT OF AUTOINFLAMMATORY DISORDERS

TREATMENT AND PREVENTION OF NEUROINFLAMMATION OR AN INFLAMMATORY BR...

TREATMENT AND PREVENTION OF A NEURODEGENERATIVE DISORDER

TREATMENT OF ARTHRITIS

MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS

NOVEL SULFONAMIDEUREA COMPOUNDS

NLRP3 INFLAMMASOME INHIBITION

NLRP3 INHIBITORS

NOVEL COMPOUNDS

PHENYLSULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS

PHENYLSULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS

SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

NOVEL COMPOUNDS

NOVEL COMPOUNDS

NOVEL COMPOUNDS

SULFONAMIDE DERIVATES AS NLRP3 INHIBITORS

NOVEL COMPOUNDS

NOVEL COMPOUNDS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS